Yahoo Web Search

Search results

1. • 

     Diagnosing Psoriatic Arthritis for the Dermatologist

     Medscape· 2 days ago

     Editor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...

2. • 

     Guselkumab Provides Long-Term Relief From PsA Symptoms

     Medscape· 2 days ago

     Guselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a...

3. • 

     Stelara biosimilar from Alvotech, Teva approved by FDA

     BioPharma Dive via Yahoo Finance· 2 days ago

     The FDA cleared Selarsdi for treatment of moderate to severe plaque psoriasis and active psoriatic ...

4. • Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...

     Morningstar· 3 days ago

     Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis ...

5. • Avior Wealth Management LLC Has $600,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

     ETF DAILY NEWS· 6 hours ago

     Avior Wealth Management LLC lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 13.4% in the 4th quarter, according to the company in its most recent Form 13F filing ...

6. • Johnson & Johnson (NYSE:JNJ) PT Lowered to $170.00

     ETF DAILY NEWS· 7 hours ago

     Johnson & Johnson (NYSE:JNJ – Get Free Report) had its price target lowered by analysts at Bank of America from $180.00 to $170.00 in a research report issued to clients and investors on Wednesday ...

7. • Plaque psoriasis plagues Marietta man for over 30 years until new treatment

     Fox local via AOL· 4 days ago

     Greg Morrison of Marietta has been struggling with plaque psoriasis and psoriatic arthritis for more than 30 years. Four months ago, he found a new treatment ...

8. • 

     Rinvoq interactions: Other medications, alcohol, and more

     Medical News Today· 3 days ago

     Rinvoq (upadacitinib) is a brand-name extended-release oral tablet prescribed for certain autoimmune...

9. • Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and...

     Digital Journal· 2 days ago

     The CAN10 surrogate also inhibited disease development in models of systemic sclerosis, psoriasis, psoriatic arthritis, atherosclerosis and peritonitis.

10. • 

      FDA Approves Second Ustekinumab Biosimilar

      Medscape· 2 days ago

      The biosimilar is expected to be marketed in the United States on or after February 21, 2025.